Mark Kelly

Stifel downgraded Molina Healthcare, Inc. (NYSE: MOH) to Sell as research analysts Thomas Carroll and Mark Kelly moved their price target to $60. Key Takeaways Carroll and Kelly do not believe “new management can successfully expand margins in the near-to-medium-term, grow revenues from a...

Molina Healthcare, Inc. (NYSE: MOH) announced first-quarter results Tuesday following an earlier announcement concerning the ouster of its CEO and chief financial officer, both sons of the healthcare company's founder. The 'Adjusted, Adjusted' Earnings Stifel in a note looked at what it termed as...